Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Cancer follows a fairly standard protocol: Cells multiply out of ...

Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...

According to DelveInsight's analysis, the market size for osteosarcoma in the 7MM is expected to grow significantly by 2034. As per DelveInsight estimates, the total incident population of ...

OS Therapies’ cancer vaccine, OST-HER2, has been shown to significantly improve overall survival (OS) in patients with recurrent, fully resected, pulmonary metastatic osteosarcoma after two years.

While genetic sequencing has previously helped to uncover different subtypes of other cancers, like breast or skin cancer, for which those patients then receive targeted treatment personalised to ...

Devonta Lee, former LSU and Louisiana Tech wide receiver, dies at 26 after battling osteosarcoma, as family, coaches and teams pay tribute ...

Regenerative Medicine Advanced Therapy (RMAT) designation requests update submitted to FDA with recent biomarker data ...

For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs ...

Osteosarcoma is a malignant neoplasm of the bone and is the most common histological form of primary bone cancer. It is most prevalent in children and young adults, as it is associated with the ...

The histopathological features of osteosarcoma vary widely, often leading to diagnostic difficulties particularly when there is little evidence of osteoid formation. The report describes the ...

There have been few reports of osteosarcoma after allogeneic bone marrow transplantation. 1 We report the development of osteosarcoma in a recipient 17 years after stem-cell transplantation. A ...